Johnson & Johnson (NYSE:JNJ) announced that it is accepting applications for its 2022 Women in STEM2D (WiSTEM2D) Scholars Award.
New Brunswick, N.J.–based Johnson & Johnson’s award aims to support assistant or associate academic professors in the disciplines of science, technology, engineering, math, manufacturing and design through three years of mentorship from leaders at the company and a total of $150,000 ($50,000 each year), according to a news release.
The company launched the Johnson & Johnson WiSTEM2D Scholars Award in June 2017 in an effort to fuel the development of female STEM2D leaders and inspire career paths in STEM2D by supporting the research of the awarded women in their respective fields.
An independent external advisory board will select the 2022 winners, each of whom will go on to represent one of the STEM2D disciplines.
“COVID-19 has shown us that investments in research are critical to advance health for humanity and, as we begin to emerge from the pandemic, there is a great need for continued progress and innovation aimed at a healthier, safer and more equitable world,” said Cat Oyler, Momenta Pharmaceuticals’ VP of clinical transformation, immunology & integration leader, and WiSTEM2D university sponsor.
“Research shows that the pandemic disproportionally affected women in WiSTEM2D, with 70% unable to obtain funding, making this award more crucial than ever,” Oyler said in the release.
